Prostate-specific membrane antigen is a type II transmembrane glycoprotein encoded by the FOLH1 gene that was initially found expressed highly on prostate cancer cells but is also expressed in the tumour-related neovasculature of several other malignancies including RCC [48]. Here, FOLH1 is linked to renal cell carcinoma.